PAM
ISEE

Paradigm Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Paradigm Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,400
Closed -$59.2K – 839
2016
Q1 		$59.2K Hold
1,400
– – 0.01% 551
2015
Q4 		$110K Buy
+1,400
New +$81K 0.02% 458

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Paradigm Asset Management's ISEE Position: Q2 2016 in Review

Paradigm Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2016, closing a stake of 1,400 shares — an estimated $59.2K sold.

Paradigm Asset Management first reported a position in ISEE in Q4 2015 and held it in 2 quarters. The position peaked at $110K in Q4 2015. 182 funds tracked by Wall St. Rank hold ISEE as of Q2 2016.

  • Paradigm Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Paradigm Asset Management sold 1,400 IVERIC bio, Inc. Common Stock shares in Q2 2016, an estimated $59.2K.
  • Paradigm Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2015 and held it in 2 quarters.
  • Paradigm Asset Management's IVERIC bio, Inc. Common Stock position peaked at $110K in Q4 2015.
  • 182 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2016.

Based on Paradigm Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.